Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy
Clinical trial NCT03077217 · COMPLETED
Trial details
- NCT number
- NCT03077217
- Sponsor
- Shanghai Changzheng Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2020-05-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.